Duopharma Biotech Bhd and the Malaysian government have executed an agreement to procure insulin via direct negotiation for RM375.17 million, a Bursa Malaysia filing said. The company said wholly owned subsidiary Duopharma Marketing Sdn Bhd (DMktg) will supply and deliver the products to the Health Ministry while Biocon Sdn Bhd, the manufacturer, will pack and label the products under the agreement. Source: The Edge Markets 1/10/2022